Venclexta (venetoclax)

pCPA File Number: 21561

Negotiation Status:

Concluded with an LOI

Indication(s):

Acute myeloid leukemia (AML) newly diagnosed in patients who are 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy (in combination with azacitidine)

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

PC0238-000

pCPA Engagement Letter Issued:

2021-09-29

Negotiation Process Concluded:

2021-12-06